September 12, 2007
News
Press Releases
Publications
In the News
Intradigm Corporation Press Releases
Intradigm Announces Allowance of Key RNA Interference (RNAi) Patent
June 17, 2008
Study Shows Intradigm’s RNAi Nanoplex Technology to Be Effective Systemic Sirna Delivery Platform for the Treatment of Various Cancer Models
April 14, 2008
Intradigm Licenses Key Next Generation RNA Interference (RNAi) Intellectual Property from University of Massachusetts Medical School
April 9, 2008
Intradigm Further Strengthens Competitive Position in RNA Interference (RNAi) Space by Licensing Key Delivery Intellectual Property from Massachusetts Institute of Technology
January 29, 2008
Intradigm Study Shows Ability of siRNAs Systemically Delivered with Targetran™ System to Suppress Tumor-Induced Angiogenesis in Mice
October 24, 2007
Intradigm selects Agilent Technologies as manufacturing partner for Novel RNA Interference Oncology Therapeutic
June 26, 2007
Intradigm announces addition of Samuel Zalipsky to management team
May 30, 2007
Intradigm announces significant enhancements of the company capabilities, a new series A financing and important addition to senior management team
Nov. 21, 2006
RNAi Therapeutic Successful for Treatment of SARS Respiratory Virus in Rhesus Macaque
Sept. 12, 2005
Intradigm Corporation Awarded National Eye Institute SBIR Funding For Treatment Of Ocular Neovascularization Diseases.
Jun. 21, 2004
Intradigm Corporation Awarded National Cancer Institute STTR Funding For Brain Cancer.
Jun. 9, 2004
Intradigm Corporation Awarded National Cancer Institute SBIR Funding For Tumor-Targeted siRNA Therapeutic.
May 20, 2004
Intradigm's ICS-283: First Demonstration of Clinically Viable, Systemically Administered RNA Interference Therapeutic Agent for Cancer and Ocular Angiogenesis.
Dec. 4, 2004
QIAGEN (QGENF) And Intradigm Corporation Initiate Collaboration Targeting siRNA Applications.
July 8, 2003
Send mail to
info@intradigm.com
with questions or comments about this web site.
Copyright © 2000 - 2007 Intradigm Corporation